April 09, 2021
Article
COVID-19 has increased the demand for new, safer curbside conveniences and the health care industry—including the pharmacy—has transformed rapidly to meet patient needs and prioritize safety as a result of the pandemic.
Opdivo-based combinations show benefit for patients with esophageal cancer who are often diagnosed after their disease has spread and would benefit from new therapeutic options.
Video
Megan May, PharmD, BCOP, Cecilia Lau, RPh, BCOP, APh, and Daneng Li, MD, share their thoughts on unmet needs in the management of neuroendocrine tumors.
The most common reason given for refusal of a COVID-19 vaccine was distrust of the health care system, correctional or government personnel, and institutions.
The experts discuss measures taken by pharmacy to prevent waste of vaccine doses and the education provided to members of the medical staff.
Madeline Camejo, PharmD, MS, leads discussion on vaccination of health care workers and the strategies implemented at their institutions to accomplish this task.
Madeline Camejo, PharmD, MS, and Michael Epshteyn, PharmD, MSM, discuss pharmacy’s involvement in the COVID-19 vaccine rollout and training pharmacists to be vaccinators.
April 08, 2021
A session at the Community Oncology Alliance virtual 2021 conference noted that clinical trials have found promising new treatments for patients with breast cancer, offering opportunities for future new approvals and indications.
Developing an antimicrobial stewardship program is arduous but valuable; commitment from leadership is the first step.
In patients who received early palliative care, researchers noted a lower percentage of patients with depression, improved quality of life, and, significantly, longer survival.
